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INTRODUCTION
“Humanity has but three great enemies fever,  famine and war; Of 
these by far the greatest, by far the most terrible is fever”.  William Osler30.
Human malaria is basically a febrile illness caused by species belonging 
to  the  genus  Plasmodium.  Malaria  has  always  been  a  major  public  health 
concern, probably representing the most important parasitic disease in human. 
Malaria is one of the most common cause for school absentism.
It has been infecting humankind for millennia. Earliest recordings of this 
disease are available from description of the Chinese and Egyptian civilization 
between 1700 & 1500 B.C. Recordings can also be found in the Vedic writings 
of 1600 BC in India. Charaka and Sushrutha gave vivid descriptions of malaria 
and even associated it with the bite of mosquitoes56. Malaria was also a scourge 
of the western civilization even at the beginning of this century.
Malaria  is  a  protozoan (Coccidiean-Apicomplexa)  disease  transmitted 
by the  bite  of  infected female Anopheles mosquitoes,  which breed in fresh 
water66.  The  species  that  infect  humans  are  four  in  number.  P.falciparum, 
P.vivax, P.ovale and P.malariae. P.falciparum is predominantly a pathogen of 
the tropics and produces a more severe form of disease. P.vivax and P. ovale 
tend  to  produce  infections  in  more  temperate  zones  that  are  less  severe. 
Infections induced by P. malariae tend to be more benign.
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A heavy burden on tropical communities poses a threat to non-endemic 
countries and a danger to travellers30. Malaria results in loss of economy and 
productivity. The annual direct and indirect cost of malaria in India has been 
estimated  to  be  an  extent  of  0.5  to  1  billion  US  dollars.  Malaria  remains 
uncontrolled to date due to various reasons viz. emergence of drug resistant 
parasite, pesticide resistant mosquito vector and non availability of suitable and 
effective malarial vaccine67.
Presently, the disease malaria seems to be a diagnostic challenge to both 
the physician and to the laboratories in most of the countries. Hence we need to 
design and review the current methodology and approach to the diagnosis of 
malaria  in  a  practical  and  cost  effective  way  helpful  for  the  patients,  the 
laboratory and for the physician caring for the patient. Concurrently the World 
Health  Organization  has  begun  a  dialogue  with  scientists,  clinicians  and 
manufacturers  of  malaria  diagnostic  test  devices  regarding  the  realistic 
possibilities for developing accurate and cost effective rapid diagnostic tests for 
malaria2.
Malaria rapid diagnostic devices (MRDD) have been developed with the 
hope that they would offer accurate, reliable, rapid, cheap and easily available 
alternative  to  traditional  method  of  malaria  diagnosis15.  Assay  for  rapid 
diagnoses  have  the  potential  to  enhance  diagnostic  capabilities  in  those 
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instances in which skilled microscopy is not readily available2. Conventional 
peripheral  blood  smear  examination  for  demonstration  of  malarial  parasite 
remains the “gold standard” for diagnosis of malaria52. The Quantitative Buffy 
Coat (Q.B.C), assay for detection of antigen Histidine rich protein (HRP –2) 
and Pan Malarial Antigen (PMA) by Immuno chromatographic test (ICT), only 
HRP –2  antigen  by  Dot  ELISA for  P.falciparum and  detection  of  specific 
nucleic acid sequences (P.f 918 bp, P.v 523 bp) by Polymerase chain reaction 
(PCR) have been studied here particularly to overcome the disadvantages of 
conventional peripheral blood smear study.
Rapid, accurate diagnosis is fundamental to effective management and 
control of malaria. Modern methods of malaria diagnosis include fluorescent 
microscopy, flow cytometry, automated blood cell analysers, serology-antibody 
detection,  molecular  methods  and  laser  desorption  mass  spectrometry 
(Hanscheid 1999,Demirev et al 2002)15, Immunochromatographic assay detect 
malarial  antigen  Histidine  Rich  Protein  2  (HRP-2)  and  enzymes  Parasite 
Lactate dehydrogenase (pLDH), aldolase and PCR. All these new technologies 
are compared with accepted “gold standard” method2. 
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HISTORY OF THE MALARIAL PARASITE AND ITS DIAGNOSIS 
Malaria  is  caused  by  the  sporozoan parasite  belonging  to  the  Genus 
Plasmodium.  Malaria,  meaning  ‘bad  air’  with  its  well  known  symptom  of 
intermittent fever has been recorded in papyri, from ancient Egypt. 
5TH CENTURY B.C. :  Hippocrates in Greece gave a detailed account of the 
clinical picture and observed the prevalence of the disease in certain places and 
seasons37.
6TH CENTURY  A.D.  :  The  relation  between  the  disease  and  stagnant
waters,  swamps  and marshy  lands  was  recognized  and measures  to  control
the  disease  by  effective  drainage  were  practiced  in  Rome  and  Greece  by
6th century A.D37.
18TH CENTURY : The name malaria ‘mal-bad, aria – air’ was given in Italy, 
as  it  was  believed  to  be  caused  by  foul  emanations  from the  marshy  soil. 
Disease named “Malaria” by Sir Horace Walpole. ‘Paludism, another name for 
malaria  also has  a  similar  origin  from palus,  Latin  for  ‘marsh’.  The recent 
demonstration of a specific parasitic antigen in Egyptian mummies indicates 
that malaria was present thousands of year’s ago37.
In 1820  :  Quinine isolated from cinchona bark in Indonesia61.
In 1880 : Alphonse Laveran, a French army surgeon in Algeria, discovered the  
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specific causative agent of malaria in the red blood cells of a patient54,61. 
In 1883: Marchiafava used Methylene blue for staining malarial parasites54, 61.
In 1886 :  Golgi in Italy described the asexual development of the parasite in 
red blood cells (erythrocytic schizogony), which therefore came to be called  
Golgi cycle61.
1886-1890  : Three  different  species  of  malarial  parasites  infecting  man,  
P.vivax, P. malariae, P. falciparum were described in Italy37.
In 1897 :   The mode of  transmission of  the  disease  was established when 
Ronald  Ross  in  secunderabad,  India  identified  the  developing  stages  of  
malarial parasites in mosquitoes. This led to various measures for the control  
and possible eradication of malaria by mosquito control. It is tragic that one 
century down we were still grappling with the problem61. 
In 1900 :  Observation of mosquito transmission by Ross was supported by  
Patric manson54, 61.
Both Ronald Ross (1902) and Alphonse Laveran (1907) won the Nobel Prize  
for their discoveries in Malaria37. 
In 1922 : The fourth species P.ovale was identified37. 
In 1948 :  Shortt and Garnhalm demonstrated the site of the exo-erythrocytic  
development  in  the  liver.  In  the  next  year,  they  demonstrated  the  pre-
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erythrocytic schizogony of P.falciparum54, 61.
In 1955 :   The World Health  organization launched a Worldwide Malaria 
Eradication  Programme.  This  continued  until  1970,  when  it  was  official  
declared a failure45, 54.
With the spread of malaria, mosquito control measures were tried. The 
first  large-scale demonstration of this  was in Cuba in 1899 and in India in 
1935-193922. The World Health Organization between 1953-1958 embarked on 
the Malaria Eradication Programme22,45. But 1972-1978 saw the resurgence of 
malaria in endemic tropical countries including India.
1965 – 1976 as part of the reorientation of the Malaria Control strategy, 
extensive scientific studies were done on the development of a malarial vaccine 
(between  1965-1976),  which  culminated  in  the  production  of  continuous
in-vitro culture technique for P. falciparum by Trager and Jensen in 1976.
National Malaria Control Programme (NMCP) was launched in India in 
April 1953. It was based on indoor residual spraying with DDT twice a year in 
endemic areas.  Government  of  India  in the Ministry  of Health changed the 
strategy from malaria control to eradication and launched the National Malaria 
Eradication  Programme  (NMEP)  in  1958.  Considering  the  resurgence  of 
malaria,  the Govt.  of India in the ministry of Health modified strategy as a 
Modified Plan of Operation (MPO) to control malaria. The Modified Plan of 
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Operation under the NMEP came into force from 1st April 1977. In 1999, the 
Govt.  of  India  decided  to  drop  the  term  “National  Malaria  Eradication 
Programme” and renamed it “National Anti-malaria Programme”56.
Serological tests - Indirect Fluorescent antibody test (IFAT) & Indirect 
Haemagglutination Assay (IHA) in study of malaria were developed in early 
1960s and there is a sustained interest in this aspect to develop an ideal test 
which would be  effective  in  the  field  trials  for  use  in  sero-epidemiological 
surveillance26.
A  test  that  could  be  easily  interpreted  within  5  to  15  minutes  of 
specimen  would  be  a  substantial  aid  to  clinicians.  Of  the  numerous  new 
techniques  developed for  the  diagnosis  of  malaria,  Quantitative  Buffy  Coat 
(Q.B.C.) technique appears to be a promising test46.
Other enzymes within the glycolytic pathway of the malarial  parasite 
have been  recognized  and considered as  target  for  rapid  malaria  diagnostic 
tests. Aldolase is a key enzyme in this pathway. Malarial antigens currently 
targeted by rapid diagnostic test are HRP-2, pLDH and Plasmodium aldolase2.
PCR  based  methods  are  particularly  useful  for  studies  on  strain 
variation, mutations and studies of parasite genes involved in drug resistance. 
The  ability  to  detect  and  distinguish  all  species  of  plasmodium  and  the 
enhanced  sensitivity  make  them  ideal  procedures  for  the  diagnosis  of
14
malaria2, 17.
The  Centers  for  Disease  Control  and  Prevention  recommends  that 
malaria should be considered in the differential diagnosis of febrile patients 
who have traveled to a region where malaria is endemic and in any patients 
who experience fevers of unknown origin regardless of their travel history43, 73.
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EPIDEMIOLOGY 
Malaria  is  one  of  the  important  parasitic  disease  of  human  being 
affecting 103 countries in the world involving a population of over 2.5billion 
people and causing 1 to 3 million deaths each year. Around 40% of the World’s 
population is deemed under malaria risk53. It is ranked with acute respiratory 
diseases and diarrhoeal diseases as one of the leading causes of the mortality 
world wide18.
GEOGRAPHICAL DISTRIBUTION : 
Malaria has been recorded in places as far north as Archangel, Russia 
and as far south as Cordoba, Argentina and in places as low as the Dead sea 
(400 meters below sea level) and as high as Cochabamba, Bolivia (2800 meters 
above  sea  level).  However,  malaria  is  essentially  a  focal  disease  and  its 
distribution is patchy in most parts28.
The relative prevalence of four species of malarial parasites varies in 
different geographical regions.  P. vivax is the most widely distributed, being 
common in Asia, North Africa and Central and South America. P. falciparum, 
the predominant species in Africa,  Papua New Guinea and Haiti,  is  rapidly 
spreading in South East Asia and India.  P. malariae is present in most places 
but is rare except in Africa. P. ovale is virtually confined to West Africa where 
it ranks second after  P. falciparum. Malaria may occur in endemic as well as 
epidemic patterns40.
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WORLD WIDE DISTRIBUTION : At the end of 2004, 107 countries and 
territories had areas at the risk of malaria transmission. Some 3.2 billion people 
lived in areas at risk of malaria transmission. An estimated 350 to 500 million 
clinical malaria episodes occur annually; most of these are caused by infection 
with P.falciparum and P.vivax75.
MALARIA IN INDIA : 65% of malaria in India is caused by P.vivax and 
35%  by  P.falciparum.  Nearly  0.98  million  cases  of  malaria  were  reported 
during  the  year  2001  of  which  nearly  0.46  million  were  falciparum cases. 
Highly endemic areas for malaria include the north – eastern region and tribal 
forested and hilly areas of several states including Maharashtra, and selected 
non-tribal districts. Nationwide, the reported incidence of laboratory confirmed 
cases  has  declined from 3.0 million  in  1996,  2.1  million in  2001 and 1.78 
million in 200375.
IN TAMILNADU : 43,604 cases were reported in 200375, Chennai in the year 
2004, 28,224 cases were reported. (Courtesy of Chennai Corporation).
TRANSMISSION : Man is the only source of malarial infection. Infected man 
suffering from acute and chronic malaria and carriers harbouring gametocytes 
are the reservoirs of malaria55. The human beings are the intermediate host; the 
female Anopheles mosquito is the definite host (vector). Malaria is transmitted 
by the bite of infected female Anopheles mosquitoes. This is the major mode of 
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transmission.  But  unnatural  methods  of  transmission  as  a  result  of  blood 
transfusion when the  donor harbours  malarial  parasite  (Bruce Chwatt  1974, 
1980) drug addiction and congenital infection of the new born from an infected 
mother (Bruce chwatt 1980) have also been reported in the first half of this 
century28.
AGENT:
 PLASMODIA :  Malarial  parasites  belong to  Phylum Apicomplexa;  Class 
Telosporea,  Order  Eucoccidia,  Suborder  Haemosporina  and  Genus 
Plasmodium.  Of  the  120  existing  species  of  Plasmodia,  only  four  are  the 
primary agents of human malaria- P.falciparum, P.vivax, P. malariae & P.ovale 
(Phillips 1983)23.
The malarial parasite passes its life cycle in two different hosts. Man 
being the intermediate host allows the asexual cycle to continue. This cycle 
consists  of  primary-erythrocytic  schizogony,  erythrocytic  schizogony,  and 
gametogony and in P. vivax alone the secondary exoerythrocytic schizogony. 
The duration of each phase varies with the species.
In Mosquitoes : The female Anopheles mosquito forms the definitive host. 
This cycle is initiated by the mosquito’s ingestion of the sexual forms (male 
and female gametocytes) developed in the human host, during the blood meal. 
Within  the  mosquito  further  development  occurs  with  the  formation  of 
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sporozoites, which are infective to man23.
Vector : only female Anopheles mosquitoes can transmit human malaria. The 
male Anopheles feeds exclusively on nectar and fruit juices while the female 
feeds on warm blooded animals.  There are about 422 species of Anopheles 
mosquitoes through out the world,  but  only some 70 species are vectors  of 
malaria under natural conditions28.
In India the predominant vector is A. culifaciens though A. fluviatilis,
A. stephensi, A. sundaicus, A. minimus and A. philippinensis also exist (Bruce 
Chwatt 1980). The vectors of major importance are A. culifaciens in rural areas 
A. stephensi in urban areas; Breed in fresh water; Anopheles mosquitoes have 
nocturnal feeding habit, between dusk and dawn28.
Environment : Variations in climatic conditions has a profound effect on the 
mosquito and the malarial parasite. A temperature of 18oC – 30oC and humidity 
of  60%-70%  are  optimal  for  the  vector  and  the  parasite.  Rainfall  is  also 
important  by  increasing  breeding  sites  and  humidity  (WHO  1979,  Bruce 
Chwatt 1980)28.
Spleen  palpation  and  peripheral  blood  examination  are  important 
methods in malaria surveillance and epidemiologic studies on prevalence of the 
disease29,63.  The  use  of  spleen  rate  as  a  malariometric  index  has  the 
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disadvantages that in areas where antimalarial measures have been instituted. 
The spleen rate classification of endemicity is not applicable (Bruce Chwatt 
1980)  and the  splenomegaly  especially  in  tropical  regions  is  a  non-specific 
sign, which may be due to causes other than malaria (Kagan 1972).
o During the past few years, there has been an increased awareness of the 
importance  of  trained  and  qualified  personnel  to  perform  diagnostic 
procedure.
o These results obtained by intensive basic research are currently leading 
to improved diagnostic procedure.
o The rapid development of new methods and techniques in the area of 
molecular  biology  has  gained  new  insights  into  the  genetic  and 
structural features of malarial parasite.
PATHOGENESIS AND PATHOLOGY OF MALARIA
The female Anopheline mosquito becomes infected when it  feeds on 
human  blood  containing  gametocytes,  the  sexual  forms  of  the  malarial 
parasites. Development in the mosquito takes from 7-20 days. The infection 
starts with the bite of an infected mosquito, when the sporozoite is introduced 
in to the skin together with mosquito saliva. The sporozoites rapidly make its 
way to  the  liver,  where  it  invades  a  hepatocyte.  Within  the  hepatocyte  the 
parasite undergoes a period of differentiation and multiplication to produce the 
pre or exoerythrocytic schizont, containing a few thousand merozoites. Rupture 
of the schizont releases more merozoites into the blood and invade erythrocytes 
where  they  develop  through  ring  forms  to  trophozoites  and  eventually 
20
schizonts.  P.vivax  invades  the  youngest  red  cells  where  as  P.  falciparum 
invades red cells of any age16.
The  pre-erythrocytic  stage  of  infection  produces  minimal 
histopathological changes and absolutely no detectable symptoms or functional 
disturbances in the host.  Pathological process in malaria is the result of the 
erythrocytic  cycle.  In  case  of  P.  vivax  and  P.  ovale  infections,  arrested 
development  of  some  sporozoites  in  liver  cells  results  in  dormant  forms, 
hypnozoites from which the infection may later relapse. P. falciparum and P. 
malariae have no persistent exoerythrocytic phase but recrudescences of fever 
may result from multiplication of parasites in the red cells which have not been 
eliminated by treatment and immune processes.
In case of P.falciparum the following changes that occur to the infected 
erythrocyte  are  altered  membrane  transport  mechanisms,  development   of 
protuberances or knobs beneath the surface membrane, expression of various 
surface neoantigens, development of cyto-adherent and rosetting properties and 
digestion of haemoglobin to pigment. The secondary effect of these changes 
are  related  to  the  host’s  immunological  response  to  parasite  antigens  and 
altered  red  cell  surface  membranes  such  as  the  stimulation  of  the 
reticuloendothelial  system,  changes  in  regional  blood  flow  and  vascular 
endothelium  and  systemic  complications  of  altered  biochemistry,  anaemia, 
tissue and organ hypoxia and cytokine production21.
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The fever, febrile paroxysms, headache, a variety of aches and pains and 
prostration,  the  most  familiar  and  consistent  symptoms of  an acute  malaria 
attacks, are probably the result of cytokines released from macrophages at the 
time of schizont rupture. The malarial toxin released at schizont rupture is the 
lipid,  glycosyl  phosphatidyl  inositol  (GPI)  anchor  of  a  parasite  membrane 
protein  (MSP1).  Cytokines  such  as  tumor  necrosis  factor  (TNF),  and
interleukin-1 (IL-1) have been implicated as the cause of malarial fever when 
the mature schizont ruptures releasing red cell fragments, merozoites, malarial 
pigment and other parasitic debris. Macrophages and polymorphs phagocytose 
these and release large quantities of endogenous pyrogens leading to elevation 
of temperature21.
Pathology : The pathology in malaria is due to haemolysis of infected red cells 
and  adherence  of  infected  red  blood  cells  to  capillaries.  Malaria  is  always 
accompanied by haemolysis and in a severe or prolonged attack anaemia may 
be profound.  Typical  pathological  changes are seen primarily  in the spleen, 
liver, bone marrow, lungs, kidney and brain.
Chloroquine resistant P. falciparum was first reported in Columbia and 
Thailand in the late 1950s55. Several mechanisms can account for changes in 
drug sensitivity in the malarial parasite.
- Physiological adaptation due to non-genetic changes, selection 
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of  previously  existing  drug  resistant  cells  from  a  mixed 
population under drug pressure.
- Spontaneous mutation.
- Mutation of extranuclear genes
- Or the existence of plasmid like factors 20
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IMMUNITY
Host immunity in malaria is of two types-
-Natural or innate immunity
-Acquired immunity
Innate Immunity:  Innate resistance is seen in certain population e.g. person 
with red cells negative for Duffy  blood group determinants are resistant to
P. vivax infections (Phillips 1983). Young babies have a reduced susceptibility 
especially to P. falciparum, probably due to maternal antimalarial antibodies 
and also the presence of haemoglobin F which is less suitable for the parasite’s 
existence  and  multiplication  (Phillips  1983).  Glucose  -6-  phosphate 
dehydrogenase deficient individuals are protected against malaria. This enzyme 
is necessary for the respiratory process of the parasite52.
P. falciparum does not multiply in sickle red cells containing abnormal 
haemoglobin S38.  Severe  malnutrition and iron  deficiency may confer  some 
protection against malaria. During severe famine in North Africa, malaria was 
rare but on providing food and iron supplements the patients began to develop 
malaria.  Spleen  plays  an  important  role  in  immunity  against  malaria. 
Splenectomy enhances susceptibility to malaria62.
Falciparum  malaria  is  more  severe  in  pregnancy  particularly  in 
primigravida,  and may be enhanced by iron supplementation.  HLA-B 53 is 
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associated with protection from malaria38.
Acquired Immunity :  Both humoral and cellular immunity play a protective 
role in malaria.
Humoral Component :  Where malaria  is  hyperendemic,  the  acquisition of 
clinically  evident  protective  immunity  in  young  children  is  associated  with 
significant increase in serum gamma - globulin and a greater increase is seen in 
adults (McGregor 1981). Of the increased gamma globulins, only 5-10% are 
associated  with  specific  action  against  the  malarial  parasite  (curtain  et  al 
1964)49.
Cellular  Immunity  :  Involvement  of  T.  lymphocytes  in  malaria  has  been 
shown experimentally (Kass et al 1971, Cohen et al 1974, Greenwood 1974, 
Allison 1981). However it has been postulated T cells do not function alone, 
but co-operate B cells for induction of specific antibody (McGregor 1981)69.
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CLINICAL MANIFESTATIONS
The  main  clinical  features  are  fever  peaks  with  rigor  followed  by 
anaemia and splenomegaly. The clinical features of malaria vary from mild to 
severe and complicated according to the species of the parasite  present,  the 
patient’s state of immunity, the intensity of infection and also the presence of 
concomitant condition such as malnutrition. 
Prodromal period :  Malarial paroxysm is preceded by a prodromal period, 
which  varies  from  a  few  to  several  days.  Non-specific  symptoms  such  as 
malaise, myalgia, headache and fatigue are usually seen during the prodromal 
period3.11.60.
Malarial paroxysm :  Occur with definite intermittent periodicity depending 
upon the species of the parasite involved. Comprises of three successive stages 
cold, hot and sweating stage4,13,71.
Cold Stage : Lasting for 15-60 minutes; the patient experience intense cold and 
shivering4,13,71. 
Hot Stage :  Lasting for 2-6 hrs, when the patient feels, intense heat. Patient 
develops high fever (40-40.6oC), severe headache, nausea and vomiting4,13,71.
Sweating stage : Patient is drenched in profuse sweat. The temperature drops 
rapidly  and  patient  usually  falls  into  deep  sleep,  to  wake  up  refreshed.
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The paroxysm usually begins in the early afternoon and lasts for 8-12 hrs. The 
periodicity  of  the  attack  varies  with  the  species  of  the  infecting  parasite
(P.v. 48 hours, P.f. 48 hours., P.o. 48-50 hours, P.m. 72 hours)4,13,71.
All clinical manifestations in malaria are due to products of erythrocytic 
schizogony and host  reactions  to them. The exoerythrocytic  liver cycle and 
gametogony do not appear to contribute to clinical illness4.
Anaemia  :  Anaemia  is  normochromic  and  normocytic.  It  is  severe  in 
falciparum malaria. The pathogenesis of anaemia appears to be multifactorial. 
These include.
- The lysis of parasitized and non-parasitized red blood cells.
- The suppression of erythropoiesis in the bone marrow. 
- Increased clearance of non-parasitized RBC’s by the spleen.
Hepatosplenomegaly : Physical examination in uncomplicated malaria shows 
moderate  splenomegaly  and  tender  hepatomegaly  or  may  even  reveal  no 
abnormalities.  Splenomegaly  due  to  massive  proliferation  of  macrophages, 
phagocytize  both  parasitised  and  non-parasitised  red  blood  cells. 
Lymphadenopathy does not occur in malaria4.
P. falciparum is the most pathogenic malaria species.
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Factors contributing to virulence of P. falciparum :
High level of parasitaemia : In P. falciparum malaria, parasite density exceeds 
more than 250,000-300,000 / ml of blood. Nearly 30% - 40% of total body 
red cells are parasitized. This is caused by invasion of erythrocytes of all ages 
(young and old) by P. falciparum. A level of 25% parasitaemia is usually fatal.
Sequestration of parasite: Sequestration means a condition of holding back of 
mature parasites in vital organs. This phenomenon is shown exclusively by P. 
falciparum  and  is  due  to  its  ability  to  cytoadhere4,13.  Once  inside  the 
erythrocytes,  P.  falciparum merozoites  produce a  protein  within erythrocyte 
surface membrane in form of a deformation called knobs. These knobs produce 
high molecular weight, strain specific adhesive protein. These proteins in turn 
mediate attachment of parasites to receptors on the endothelium of capillaries 
and venules. This causes sequestration of parasitized erythrocytes in the small 
post  capillary  venules  of  the  internal  vital  organs  specifically,  the  CNS, 
kidneys, spleen and lungs4,13.
Gametocyte – infected erythrocytes do not have any knobs, so do not 
stick to the venular endothelium, hence are not sequestrated, and therefore 
are  demonstrated  in  the  peripheral  blood  smears.  This  phenomenon  of 
sequestration does not occur in any other malarial parasites.
Cytokines : P. falciparum produces a number of cytokines such as IL-1, 
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TNF and IFNγ. These cytokines act specifically on a number of receptors 
present on the surface of endothelial cells in the small capillaries and post 
capillary venules49.
P. vivax malaria may not initially present with the classical symptoms, 
due to the release of non-synchronous broods of parasites. Herpes labialis is 
common  in  vivax  malaria.  Cerebral  irritation,  polyuria  and  in  children 
fulminant  infections  and severe  anaemia have been reported (Bruce Chwatt 
1980). Vivax malaria is important not due to its fatality but due to the debility it 
can produce by its relapses (Bruce Chwatt 1980).
When more than  3% -  5% of  erythrocytes  are  parasitized,  the  condition is 
known  as  severe  falciparum  malaria  Complications  of  severe  falciparum
malaria are4,13.
- Pernicious malaria 
- Black water fever
- Tropical splenomegaly 
- Pulmonary oedema
- Renal failure
- Hypoglycaemia with lactic acidosis
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DIAGNOSIS OF MALARIA
The diagnosis of malaria can be subdivided into clinical and laboratory 
which include parasitological, serological and molecular biological detection70.
Importance of diagnostic methods in malaria:
- Diagnosis of individual cases.
- Prognosis of cases.
- Monitoring drug resistance.
- Epidemiological studies.
Clinical  Diagnosis  :  The condition is  considered in  any person who has  a 
febrile illness and who has come from the area endemic for malaria, received 
blood transfusion or used intravenous drugs55.
Laboratory diagnosis :
Specimen : Peripheral blood : Under strict aseptic precautions blood 
obtained by pricking a finger or earlobe is the ideal sample because the density 
of developed trophozoites or schizonts is greater in blood from this capillary 
rich area2.
Venous  blood  : Under  strict  aseptic  precautions  blood  obtained  by 
venepuncture collected in presterilized aliquot with anticoagulant heparin or 
sequestrine (EDTA) is acceptable for making smear if used shortly after being 
drawn  to  prevent  alteration  in  the  morphology  of  white  blood  cells  and
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malarial  parasite.  Blood  should  be  taken  at  any  time  over  the  course  of 
infection before starting antimalarial  treatment,  but  the best  time is midway 
between paroxysm of chills and fever when the greatest number of intracellular 
organisms are present55.
Parasitic  diagnosis  :  Parasitic  diagnosis  depends  on  the  demonstration  of 
parasite in the blood.
Methods of examination :
1. Light Microscopy – Thick & Thin peripheral smear
2. Fluorescence microscopy :
- Quantitative Buffy Coat (Q.B.C.)
- Acridine Orange Staining (A.O.)
- Benzo thio Carboxy Purine Staining (B.C.P.)
3. Micro Concentration technique 
Light Microscopy : Conventional light microscopy of stained blood smear is 
the “gold standard” for confirmation of malaria. Both thick and thin smears are 
prepared  from  the  capillary  blood.  They  are  stained  with  one  of  the 
Romanowsky’s  stains  such  as  Leishman’s’,  Fields’,  Wrights’,  Giemsa’s  or 
Jaswantsingh Bhattacharjee stain55.
Thick Smear : The thick blood film concentrates the layer of red blood cells 
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on  a  small  surface  by  a  factor  of  20  to  30  and  is  stained  as  an  unfixed 
preparation. The thick blood film provides enhanced sensitivity of the blood 
film technique and is much better than the thin film for detection of low levels 
of  parasitaemia  and  reappearance  of  circulating  parasites  during  infection 
recrudescence  or  relapse.  Atleast  100-200 fields,  each containing  20  WBC, 
should be examined before a thick smear is reported as negative for malaria2.
It is not used for species diagnosis.
Thin  Smear  :  Because  of  the  fixed  monolayer  of  RBC  available  in  this 
procedure, the morphological identification of the parasite to the species level 
is much easier and provides greater specificity than the thick-film examination. 
The thin film is often preferred for routine estimation of parasitaemia because 
the organisms are easier to see and count.  The ability  to count parasites  in 
sequential  blood  films  enables  the  response  to  therapy  to  be  monitored, 
particularly for P. falciparum infection2, 31. 
The diagnosis of malaria is ruled out by obtaining negative thick blood 
smears  on  atleast  three  different  occasions.  (12-24 hrs;  3  subsequent  days) 
Light Microscopy is a sensitive method. In the hand of a skilled microscopist
5-10 parasites / µl of blood can be detected by microscopy. Microscopy is the 
most inexpensive test to confirm malaria55.
Although more stable stains are now available, the staining process may 
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take up to 60 minutes of preparation time to produce a stained thin or thick film 
and  is  labor-intensive.  Interpretation  requires  considerable  expertise, 
particularly  at  low  levels  of  parasitaemia.  In  addition  patients  with
P. falciparum malaria may have parasites sequestrated in the deep capillaries 
(Spleen, liver,  bone marrow), and organisms may not be seen in equivalent 
numbers  in  circulating  peripheral  blood  obtained  by  venepuncture  or 
fingerstick. Thus a P. falciparum infection may easily be missed because there 
are  insufficient  numbers  of  parasites  for  detection  in  the  blood  films.  Post 
treatment examination of blood film can result in the observation of a number 
of  circulating  parasites;  however,  the  organisms  may  be  the  non-viable 
parasites yet to be cleared by host, thus prolonging the assumed positivity of 
the patient and extending treatment2.
Chinese workers recommend that intradermal smear to be taken from 
multiple punctures on the upper forearm using a 25-gauge needle. The puncture 
should not bleed, but a serosanguinous fluid can be expressed on to a slide by 
squeezing. This method is said to have a better sensitivity for diagnosing as this 
can pick up cases in which the blood smear may be negative due to peripheral 
sequestration39.
Q.B.C. Assay  :  In 1976, Stephen Wardlaw and Robert  Levine invented the 
Q.B.C.,  both  of  them  expanding  the  utility  of  Q.B.C.  as  a  general 
haematological  tool  for  humans  and  animals  and  a  means  of  diagnosing 
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haemoparasitic diseases. This is a sensitive method for detection of malarial 
parasites.  It  is  based  on  ability  of  acridine  orange  to  stain  nucleic  acid 
containing parasites and leucocytes take up the dye, which is fluorescent when 
examined  under  a  fluorescent  microscope.  Acridine-orange  stained  malarial 
parasites appear brilliant green. This elegant method is easy to perform, easily 
interpreted within 5-15 minutes. Q.B.C. is more sensitive method than the thick 
blood smear. It can detect as low as 3-4 parasites /µl, of blood 7,46,55,59,70 Q.B.C. 
assay has advantages beyond any doubt in terms of speed, ease, reliability and 
sensitivity in diagnosis of malaria. In addition it has been of immense help in 
identifying the infective carriers with a very low parasite burden. Macroscopic 
examination of QBC tube often enables to predict a positivity of malaria. It has 
also  been  noted  that  colour  of  plasma  in  buffy  coat  also  indicates  about 
anaemia59.
QBC  assay  has  also  been  helpful  in  detection  of  microfilaria  after 
Hetrazan provocative test and / or night blood examination ; Other uses are the 
diagnosis of relapsing fever and to study the haematological parameters (e.g.) 
hamatocrit platelet count, WBC count etc.,59
Disadvantage : Cost
   Species identification is not possible
A.O. Staining method : In this method blood smears are prepared on a 
slide and are stained with acridine orange. This results in a differential staining 
of the malarial parasites. Nuclear DNA is stained green and cytoplasmic RNA 
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red, and aids in the identification of the malarial parasite. The stained slide is 
examined either with a fluorescence microscope or a microscope equipped with 
an  interference  filter  system (Kawamoto1991),  allows  quicker  screening  of 
films, because parasites are more readily recognized and a lower power lens 
may be used.42,44,46,51,55,70. 
Benzothio  carboxy  purine  (BCP)  staining  :  BCP  can  be  applied 
directly to a lysed blood suspension or to an unfixed but dry thick blood film 
and intensely stains the nucleic acid of parasites after penetrating RBCs. The 
dye does not stain nuclei of WBCs. This is useful in field laboratory for mass 
screening because of rapid staining and evaluation but it requires a fluorescent 
microscope2,10.
With  experience,  workers  using  methods  involving  fluorochrome 
compounds are able to detect parasites  rapidly and accurately.  However,  an 
important limitation of method, involving both A.O. and BCP is their inability 
to easily differentiate among Plasmodium species2.
Microconcentration technique: Blood is collected in microhaematocrit 
tube and centrifuged at high speed. The sediment is mixed with normal serum 
and smear prepared. Although, the positivity rate is increased by this technique, 
but there is change in morphology of the parasite10. 
Serodiagnosis :
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Immunological  methods  provide  the  means  for  detecting  either  the 
parasite  antigens  or  the  host  antibodies  directed  against  the  parasite.  The 
detection of antigens may be an acceptable alternative to parasite  detection, 
particularly if the assay is robust, inexpensive, easy to use in field conditions 
and  does  not  require  a  microscope,  but  the  detection  of  antibodies  merely 
provides  information  on  past  malaria  experience  and  is  of  limited  use  for 
individual diagnosis70.
Serological tests commonly used for detection and measurement of 
malarial antibodies26 :
Test Current application
Immuno precipitation Epidemiological studies and research
Indirect fluorescent antibody test (IFAT) Epidemiological studies, research and aids to diagnosis
Indirect Haemagglutination (IHA) Epidemiological surveys
Enzyme Linked Immunosorbent Assay Epidemiological studies and aid to diagnosis
Radio immuno assay Research
Merozoite inhibition in culture Research
Serology  cannot  match  the  sensitivity  of  microscopic  detection  of 
malarial parasite, but may assist diagnosis of light infection. It has got limited 
value in clinical diagnosis because they will not differentiate between an active 
and  a  past  infection10.  Serological  methods  of  diagnosis  of  malaria  have 
become of practical value since 1962 when the Indirect fluorescent antibody 
test  (IFAT)  was  introduced.  Serological  tests  are  of  value  in  providing  a 
retrospective  confirmation  of  malaria  infection  and  are  also  used  for 
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epidemiological  purpose  when  parasitaemia  is  low.  Other  applications  of 
serological techniques are the diagnosis of hyperactive malaria splenomegaly 
and the screening of blood collected for blood banks. It should be remembered 
however that these tests are of limited value in diagnosis of acute phase of 
diseases in high prevalence areas26.
ANTIGEN DETECTION :
In contrast to antibody detection, where blood as well as plasma and 
serum  can  be  used,  a  positive  antigen  detection  assay  is  most  useful  in 
detection of current infection. The ideal target antigen
- It should not persist after parasitaemia disappears.
- Should  be  abundant  in  the  blood  (or  other  bodily  fluids  such  as 
urine) to maximize sensitivity.
- Should be highly specific to malaria without any cross reactions70.
Tests  for  detecting  malarial  antigens  are  based  on  either  an  antigen 
capture or an antigen competition format and often use ELISA or the Radio 
immuno assay (RIA) methodology. Once optimal reagents have been identified 
(i.e.  monoclonal  or  polyclonal  antibodies  to  specific  malarial  antigens)  the 
assay may be simplified using a simple agglutination or dipstick method. The 
best  antigen  detection  assay  described  have  a  maximum  sensitivity  of 
0.01-0.001% parasitaemia. (Mackey et al 1982. Fortier et al Khushmith et al 
1987, Taylor and Voller 1993)70.
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Malarial antigens currently targeted by rapid diagnostic test (RDT) are 
HRP-2, pLDH and Plasmodium aldolase.
Histidine rich protein : (HRP) 
P.  falciparum infected RBC’s synthesize  three histidine-rich proteins, 
HRP-1,  HRP-2  &  HRP3.  HRP-1  was  identified  in  all  knob-positive
P.  falciparum parasites.  HRP-2 was identified in all  P.  falciparum parasites 
regardless of the knob phenotype and was recovered from culture supernatants 
as a secreted water-soluble protein. HRP-3 was present at the lowest abundance 
compared to HRP-1 & HRP-2. Neither HRP-1 nor HRP-2 was found in a range 
of other knob-positive and negative strains of non-P.falciparum malaria. HRP-2 
is a water soluble protein produced by asexual stages and young gametocytes 
of P. falciparum. It is expressed on the RBC membrane surface and because of 
its abundance in P. falciparum it was the first antigen to be used to develop on 
RDT for its detection2. 
pLDH and aldolase
pLDH  an  enzyme  found  in  the  glycolytic  pathway  of  the  malarial 
parasite  is  produced by sexual and asexual  stages of the parasite.  Different 
isomers of pLDH for each of the four Plasmodium species infecting humans 
exist, and their detection constitutes a second approach to RDT development. 
Several  other  enzymes  of  the  malarial  parasite  glycolytic  pathway,  notably 
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aldolase have been suggested as target antigen for RDT for species other than 
P. falciparum2.
Enzyme parasite lactate dehydrogenase (pLDH) detection had been used 
to monitor in vitro drug susceptibility assay (Makler and Hinrichs 1993). Now 
it has also become useful for detection of Plasmodium parasitaemia (Knobloch 
and  Henk  1995).  The  principle  of  this  assay  is  that  pLDH  has  different 
biochemical  characteristics  from  human  LDH  and  may  therefore  be 
differentially measured using a simple colorimetric assay. This assay can be 
used  for  both  quantitative  and  qualitative  estimation  of  parasitaemia;  Can 
detect as low as 0.1% parasitaemia; not species specific. Now the sensitivity of 
the assay has been currently improved, by combining it with an antigen capture 
method using a monoclonal antibody to pLDH; this improves sensitivity 100 
times (Piper et al 1995)70.
RDT dipstick format kits for the detection of malarial antigens are now 
commercially  available.  Many  field  and  laboratory  studies  have  been 
completed  that  compare  immunochromatographic  methods  with  results 
obtained by conventional microscopy, fluorescence microscopy and PCR2.
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Assay for detection of HRP-2
Three commercial dipstick formats for HRP-2 detection are
- Parasight-F
- ICT Pf
- PATH FALCIPARUM, Malaria IC.
Parasight F (Shiff, Premij and Minjas 1993) is a commercial detection 
test  in dipstick format in which a monoclonal antibody captures,  a  specific 
antigen of P. falciparum (HRP2, a molecule present in the parasite throughout 
the erythrocytic cycle) if antigen is present a positive result is indicated by a 
visible line on the dipstick12,32,70.
Advantage :
1. Rapid and Simple
2. Takes only 10 minutes.
This simple, robust assay requires no additional equipments or trained 
personal; Can be used in field surveillance.
Disadvantage :
1. Cost
2. Quantitation is not possible12,70.
Since HRP-2 is expressed only by P. falciparum these tests will  give 
negative results with samples containing only P. vivax, P. ovale or P. malariae; 
many  cases  of  non-falciparum  malaria  may  therefore  be  misdiagnosed  as 
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malaria negative. HRP-2 antigen has been shown to persist and is detectable 
after  the  clinical  symptoms of  malaria  have disappeared and parasites  have 
apparently been cleared from the host2. 
Assay for detection of pLDH
The commercial  dipstick  format  for  pLDH detection  is  OptiMAL-IT 
assay.  This  assay  is  based  on  the  detection  of  intact  and  functional  pLDH 
specific for P. falciparum and pan-pLDH (PMA) an antigen that is common to 
all  four  species  of  malaria  in  whole  blood.  The  test  uses  two  specific 
monoclonal antibodies that have been immobilized across the test strip2.
The  OptiMAL  rapid  malaria  test  is  a  patient  point  of  care 
immunochromatographic test that can be performed with a drop of finger stick 
blood.  The  entire  process  takes  approximately  15  minutes  and  results  are 
visually  interpreted.  The OptiMAL dipstick compared well  with blood film 
microscopy  for  monitoring  antimalarial  treatment  and  could  be  a  useful 
replacement for microscopy to monitor treatment in places where facilities for 
microscopy are either lacking or inadequate. In developed countries it could be 
a useful adjunct to blood film microscopy and it permits a reduction in duration 
of hospitalization and give an early warning of treatment failure31, 68.
The ICT Malaria P.f/P.v.: This is a rapid in vitro immunodiagnostic 
test  for  the  detection  of  circulating  P.  falciparum  HRP-2  and  an  antigen 
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common to all four species of malaria, pan malarial antigen (PMA) in whole 
blood.  The  test  uses  two  specific  monoclonal  antibodies  that  have  been 
immobilized  across  the  test  strip.  The  results  are  interpreted  within  10 
minutes19,  31,  35,  74.  A  limitation  of  this  test  is  that  it  cannot  speciate
P. falciparum mixed infections.
DOT ELISA FOR P. falciparum : Polyclonal antibodies to HRP-2 antigen 
are coated to the Nitrocellulose membrane. Antigen present in plasma / serum 
binds  to  this  antibody.  A  revealing  antibody  with  high  sensitivity  and 
specificity is added. The resulting complex is detected using enzyme substrate 
reaction. Appearance of brown coloured dots on 2 NC tips indicates positive 
result.
- This kit detects the P. falciparum specific HRP-2 antigen.
- No specialized training required for use of the kit.
Urinary antigen in Malaria :
- Rodriguez  del  et  al  (1991)  first  demonstrated  that  diagnosis  of 
falciparum malaria can be made by detection of specific antigen in 
the urine.
- Detection  of  urinary  antigen  offers  non-invasive,  easy  and  safe 
alternate means of diagnosis of parasitic infections not only in the 
field conditions but also in routine clinical laboratories.
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- The main advantage of  testing the  urine  is  that  unlike  blood and 
serum,  which  need  to  be  collected  by  an  invasive  procedure 
requiring technical expertise and disposable syringes, the collection 
of urine is a non-invasive procedure.
- The urine specimens can be collected easily and frequently without 
causing any inconvenience to the patient. 
- This would make the urine as a specimen of choice, particularly in 
children,  elderly  and  those  unwilling  to  give  their  blood  for 
investigation47.
Molecular Technique :
Molecular metholds based on DNA amplification have been applied to 
malaria diagnosis since the late 1980s. Their value lies in their high sensitivity, 
detecting < 5 parasites / µl. With nested or seminested PCR methods targeting 
the small – subunit 18S r RNA gene, all four species could be identified. PCR 
also  showed  increased  sensitivity  in  comparison  to  microscopy  for  the 
diagnosis of mixed infection. Unfortunately, these conventional PCR assay are 
technically demanding and time consuming. Moreover, they are prone to carry 
over contamination during the manipulation of post amplification products, a 
problem already observed in  the  unique  study testing  the  use  of  PCR as  a 
routine method for malaria diagnosis50.
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Real time PCR methods are a recent development of established PCR 
methodologies.  They  use  fluorescent  labels  for  continuous  monitoring  of 
amplicon  formation  throughout  the  reaction.  The  advantages  of  these 
techniques are quantification of pathogen, reduced risk of contamination and 
availability of results within 3 hours (including sample preparation)50,58.
PCR
- Highly sensitive technique
- Highly species specific
- Can detect parasites in dried blood specimens
- Detect drug resistant in P. falciparum
- A single  P.  falciparum  can  be  detected  in  20  µl  of  blood  using 
PBRK-1 primer, 100 times more sensitive than of thick smear55.
The application of DNA or RNA hybridization to malaria diagnosis has 
several  advantages  over  traditional  methods.  Although  the  methodology  is 
never likely to be useful at the peripheral level of health care in its present 
form,  it  may  have  a  place  as  a  research  tool  to  monitor  malaria  control 
programmes, to perform quality control checks on microscopic diagnoses or to 
determine the distribution of important genes (e.g. genes associated with drug 
resistance). 
In these methods, a known sequence of nucleic acid (oligonucleotide) is 
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synthesized  and  labeled  either  with  radioactive  32p or  a  non-radioactive 
colorimetric  reagent and this ‘probe’ is  used to detect  parasite nucleic acid, 
taking advantage of the fact that complementary sequences will hybridize.
The  simplest  version  of  this  technique is  the  use  of  DNA probes  to 
detect parasites directly in a drop of patient’s blood immobilized on a filter 
paper (Franzen et al 1984); in this test format, the sensitivity and specificity of 
the  technique  expends  largely  upon  the  choice  of  nucleic  acid  sequence. 
Species-specific small subunit ribosomal RNA sequence help to differentiate 
between P. falciparum, P. vivax, P. ovale, or P. malariae (snoop et al 1993)70
DNA probe : - Highly sensitive
- Detect low parasitaemia
- Useful to detect drug resistance.
Recent  improvement  in  molecular  technologies  like  nucleic  acid 
hybridization  and  PCR  has  come  to  the  diagnostic  field  with  immense 
promises. Nucleic acid probes to either DNA or RNA have shown to be highly 
specific for target sequences of all the four species of human plasmodium. PCR 
method because of its high sensitivity has been utilized for screening of blood 
donors to exclude transfusion malaria.  PCR assay has also been utilized for 
epidemiological study of malaria7.
CULTURE :
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Culture  is  not  used for  routine  diagnosis  of  malaria.  Bass  and Johns 
(1912) reported for the first time the in vitro cultivation of malaria parasites
(P.  falciparum  and  P.  vivax).  In  1976,  Trager  and  Jensen  successfully 
cultivated and maintained P. falciparum in vitro in human red blood cells. In 
this procedure, culture medium consisted of RPMI 1640 medium, a thin layer 
of stationary human blood cells and an overlay of medium containing human 
serum,  maintained  under  an  atmosphere  with  7%  Co2 and  1%  -  5%  O2. 
Recently  various  modifications  of  the  culture  media  have  been  described. 
Rabbit serum or bovine serum supplemented with hypoxanthine has been found 
to support parasite growth, though at a reduced rate. P. falciparum now remains 
the only parasite widely cultivated in its asexual intra-erythrocytic stage.
Invitro culture of malarial parasites at different development stages is 
essential for
- Studies on the mechanism of invasion of erythrocytes by merozoites.
- Analysis of parasite antigen and the isolation of protective antigens 
for  the  development  of  vaccines,  and  as  source  of  antigen  for
sero-epidemiological studies.
- Bio-chemical  and  metabolic  studies  including  stage  specific
changes and
- The study of sensitivity or resistance of parasites to various drugs55.
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Treatment :
Treatment of malaria is primarily based on
- Specific antimalarial chemotherapy
- Supportive therapy.
Antimalarials inhibit growth of malarial parasites by increasing internal 
pH of parasites  by concentrating within acid vesicles of parasite.  They also 
inhibit  utilisation  of  haemoglobin  and metabolism of  parasite.  Chloroquine, 
Quinine, Quinidine, Mefloquine, halofantrine and artemisinin compounds are 
the rapidly acting drugs for treatment of acute malaria55.
Chloroquine  is  the  drug  of  choice  for  drug  sensitive  P.  falciparum.
It is used for treatment of cases with acute uncomplicated P. falciparum malaria 
and  for  prophylaxis.  A  combination  of  sulphadoxine  and  pyrimethamine 
(fansidar)  was  used  for  treatment  of  chloroquine  resistant  P.  falciparum. 
Fansidar  resistant  P.  falciparum has  also  been  reported  in  the  early  1980s.
Mefloquine is a blood schizonticide. It is used for prophylaxis or treatment of 
multidrug  resistant  P.  falciparum  malaria.  Recently  mefloquine  resistant
P. falciparum have also been reported from several endemic areas of the world. 
Artemisinin  and  its  derivatives  are  the  newer  antimalarials  being  used  for 
mefloquine - resistant and multidrug resistant cases of P. falciparum malaria.
Chloroquine  and  primaquine  are  the  two  drugs  of  choice  for  the 
treatment of vivax malaria. Chloroquine is given to treat the erythrocytic stages 
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of  the  parasites  and  primaquine  to  treat  the  persistent  hypnozoite  stage  of 
parasites54.
Prevention :
Chemoprophylaxis :
Chemoprophylaxis  for  travelers  visiting  endemic  areas  provides 
effective  protection.  The  prophylactics  of  choice  include  chloroquine 
primaquine,  proguanil,  amodiaquine  and  Fansidar  in  weekly  doses  or
doxycycline daily. Long-term use of antimalarial prophylactics may produce 
serious side effects10,55.
Immunoprophylaxis :
A number of vaccines have been tested during last three decades. SSP-2 
is currently the most likely vaccine of promise for use in falciparum malaria. 
The  most  current  approach  is  cocktail  vaccine,  which  makes  use  of 
combination of  multiple  epitopes  from different  malarial  antigens  and from 
different stages of parasite in its life cycle55.
Control Measure :
Vector control is still one of the primary weapons to control malaria in 
endemic  areas.  The  spraying  of  the  indoor  surface  of  houses  with  residual 
insecticides (DDT, Malathion, fenifrothion) is still the most effective measures 
to  kill  the  adult  mosquitoes.  Man-vector  contact  can  be  reduced  by  other 
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preventive measures such as the use of repellents, protective clothing, bed nets 
(impregnated with delta methrin) and mosquito coils56a.
Biological  measures  include  -  larvicidal  fish  (Gambusia)  and  Bio-
pesticides  (Bacillus  thuringiensis  var  israelensis  H14)  and  physical  control 
measures  are  covering  of  over-head  tanks,  land  filling,  meshed  doors  and 
windows. Thus malaria can be controlled by effective vector control measures. 
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AIMS AND OBJECTIVES 
i. To meet the need for a reliable diagnostic adjunct to microscopy for 
malaria in the clinical settings.
ii. To overcome the problem of time constraints and low sensitivity in 
diagnosing  malaria  with  a  low level  of  parasitemia  by  peripheral 
blood smear microscopy.
iii. To study the efficacy and accuracy of recent techniques to diagnose 
malaria.
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MATERIALS AND METHODS
The  present  study  on  “Recent  advances  in  laboratory  techniques  for 
diagnosis  of  malaria”  was  conducted  in  the  Department  of  Microbiology, 
Stanley Medical  College and Hospital  during the period from May 2004 to 
April 2005 in collaboration with the Department of Medicine and Jawaharlal 
Nehru Institute of Social Paediatrics.
The study group includes :
I. 190 patients clinically diagnosed as malaria.
II. 20 patients diagnosed as Enteric fever - Disease Control 
III. 20 apparently healthy individuals - Healthy Control.
Total of 230 blood samples were collected, of these 190 blood samples 
were collected from clinically diagnosed as malaria patients with symptoms of 
fever  and  chills  irrespective  of  age  and  sex.  20  blood  samples  each  were 
collected from patients diagnosed with enteric fever (disease control) and from 
healthy individuals (healthy control). The criteria for the selection of healthy 
control were the history of absence of fever for a period of one month prior to 
the study. 
190  cases  of  clinically  diagnosed  malaria  and  control  group  n=40 
(disease control, healthy control) were tested by Peripheral blood smear and 
Quantitative  Buffy  Coat  (QBC).  From  the  190  cases  61  were  selected  by 
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simple  random  method  and  tested  by  recent  diagnostic  tests  such  as 
Immunochromatographic test for antigen detection (HRP-2 and pLDH), DOT 
ELISA for P. falciparum, DRDE (HRP-2 antigen) and P.C.R. assay.
Control  groups  (20  disease  control  and  20  healthy  control)  were 
subjected  to  Immuno  chromatographic  test  (Now  ICT),  DOT  ELISA  for 
Plasmodium falciparum (DRDE) and P.C.R. assay.
Collection of Blood Samples :
Under strict aseptic precautions, thick and thin peripheral blood smears 
were prepared by finger prick, and 3-5 ml of blood samples were collected in a 
pre-sterilized aliquot with anticoagulant (EDTA) by venepuncture under strict 
aseptic  precautions  from  the  patients  seeking  treatment  in  in-patient  and 
outpatient department of Government Stanley Hospital before administration of 
anti malarial drug.
Transport and storage of samples :
The  blood  samples  collected  from  patient  were  transported  to  the 
laboratory immediately. Thick and Thin smears were prepared and stained by 
JSB technique. Q.B.C. assay was also carried out simultaneously. Remaining 
portion of the samples was aliquoted and stored at 4-8oC for subsequent ICT, 
Dot ELISA for Plasmodium falciparum and PCR assay.
Methodology :
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I. Peripheral blood smear :  Thick and thin peripheral blood smears 
were prepared on a clean grease free glass slide.
a. Thin smear : Smears were air dried, fixed with methanol, dipped 
in JSBII stain for 2-3 sec, washed with buffer water to remove 
excess stain, dipped in JSB I stain for 40-50 sec and air dried.
b. Thick smear : The smears were dehaemoglobinized using buffer 
water for 5-10 minutes and continued the staining procedure as 
for thin smear. Both thick and thin smears were examined under 
oil immersion. 
II. Q.B.C. Assay (Quantitative Buffy Coat)
The Q.B.C. blood parasite detection system consists of capillary tubes 
coated  with  acridine  orange,  floats,  closures,  a  capillary  tube  holder, 
microcentrifuge  and  an  ordinary  light  microscope  with  customized 
fluorescence – paralens attachment.  The QBC capillary tube was filled with 
about 50-60 µl of blood soon after the collection. The blood was mixed with 
the  precoated  contents  (acridine  orange  and  potassium  oxalate)  by  gently 
rotating and tilting the tube atleast five times. The cap was firmly affixed and 
the  float  inserted inside  the  tube.  The  Q.B.C.  tube was  then centrifuged at 
12,000 rpm for 5 minutes. The tube was mounted on the capillary tube holder 
and examined using the  paralens  under  60 X oil  immersion  objective.  The 
Q.B.C.  tube  was  examined  for  atleast  20  Q.B.C.  fields.  The  parasites  are 
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concentrated in defined areas within the tube, which result in great reduction of 
examination times to 1-3 minutes.
The principle of Q.B.C. is based on the fact that on centrifugation at a 
high speed, the whole blood separates into plasma, buffy coat and packed red 
cell layer. The float gets buoyed by the packed blood cells and is automatically 
positioned  within  the  buffy  coat  layer.  Blood  cells  in  the  buffy  coat  layer 
separate  according  to  their  densities;  platelets  remaining  at  the  top, 
lymphocytes and monocytes within the middle layer and granulocytes at the 
bottom.  Due  to  acridine  orange  the  malarial  parasite  stains  green  (DNA, 
nucleus) and orange (RNA, cytoplasm). The tube is examined in the region 
between  the  RBC  and  granulocytes  and  within  the  granulocytes  and 
mononuclear cell layer where parasites are most abundant.
Immunochromatographic test (detection of HRP-2 and PMA) 
Test Principle :  This is a rapid in vitro immunodiagnostic test for the 
detection of circulating P. falciparum HRP-2 and an antigen common to all 
four species of malaria, pan malarial antigen (PMA) in whole blood. The test 
uses two specific monoclonal antibodies that have been immobilized across the 
test strip. One antibody is specific for the histidine-rich protein-2 antigen of 
P.f., (HRP-2). The other antibody is specific for an antigen that is common to 
all four plasmodium species.
A procedural control line is also immobilized across the test strip and 
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will always appear in area C of the test window, if the test has been performed 
correctly. 15µL of whole blood is applied to a sample pad impregnated with 
colloidal  gold-labeled  antibodies,  which  are  directed  against  the  malarial 
antigens. When a positive sample is applied, malarial antigens bind to the gold-
conjugate antibodies in the sample pad. Reagent is then added which allows the 
immune  complexes  formed  to  migrate  along  the  test  strip  where  they  are 
captured by the immobilized antibodies. When capture occurs, one or two pink 
lines will form in the test window. When a negative sample is applied only the 
control line will appear.
Test Procedure :
- All test components were brought to room temperature prior to use.
- With EDTA capillary tube blood sample was applied to cover the entire 
purple sample pad.
- Two drops  of  Reagent  A was  applied  to  the  white  pad  immediately 
below where the blood was applied.
- Four drops of Reagent A was applied to the pad located at the top of the 
left hand side of the test card.
- Adhesive  on  the  right  hand  side  of  the  test  card  was  removed  and 
discarded.
- The blood sample was allowed to run up the full length of the test strip.
- The card was closed immediately. 
- The result was read through the viewing window after 10 minutes. 
Interpretation :
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Plasmodium falciparum infection : A positive test result is indicated by any 
visible line in the test window next to T1 together with a line in area C.
Plasmodium  falciparum  infection  or  a  mixed  infection  (Plasmodium 
falciparum,Plasmodium ovale, Plasmodium malariae, Plasmodium vivax) : 
A positive test result is indicated by any visible line in the test window next to 
T1 and T2, together with a line in area C.
Plasmodium ovale, Plasmodium malariae, Plasmodium vivax or a mixed 
infection of all three : A positive test result is indicated by any visible line in 
the test window next to T2, together with a line in area C.
Negative Test Result : The test is negative if only the C line appears.
DOT ELISA FOR P. falciparum (DRDE) : 
Test Principle :  Rabbit polyclonal antibodies to HRP-2 antigen are coated to 
the Nitrocellulose membrane. Antigen present in plasma/serum binds to this 
antibody.  In  the  next  step  a  revealing  antibody  with  high  sensitivity  and 
specificity is added. The resulting complex is detected using enzyme substrate 
reaction. Appearance of brown colored dots on 2 NC tips indicates positive 
result and a brown dot on 1 NC tip indicates negative result.
Test Procedure :
 All the kit contents were brought to room temperature.
 The cap of 2-tip NC vial (Green cap vial) was labeled. 
 5 drops of dilution buffer were added on the NC tips in the green cap.
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 1 drop of blood sample was added in the containing dilution buffer and 
incubated at room temperature for 20 minutes; discarded the contents after 
incubation.
 Few drops  of  wash  buffer  were  added in  the  vial  cap  with  the  help  of 
syringe and rings. Then 1 ml of wash buffer was added in the vial; this vial 
was  closed  with  cap  containing  NC tips  and incubated  with  the  diluted 
sample; shake vigorously for 20 to 30 seconds for washing the NC tips; 
discarded the contents. 
 1 ml of fresh wash buffer was added and the washing was repeated.
 Again the used wash buffer was discarded and the cap was dried.
 4 drops of monoclonal antibody was added and incubated for 20 minutes at 
room temperature; washing was repeated as before.
 4 drops of conjugate was added over the NC tips in the cap and incubate at 
room temperature for 20 minutes; washing was repeated for 3 times
 Half spoon of substrate powder was added in the vial. The vial was half 
filled with substrate buffer and closed with cap.
 The vial with substrate solution was shaked vigorously for 2 to 3 minutes 
and the appearance of colored dots on the NC tips was observed. 
Interpretation :
Appearance of a colored dot only at one NC tip indicates a negative 
result. Appearance of colored dots in both NC tips indicates positive result for 
P. falciparum antigen.
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PCR Amplification of target DNA sequence :
Chromosomal DNA preparation :
Chromosomal DNA was extracted from about 300  µl of whole blood 
with a slight modification of the standard procedure of Maniatis  et al (1982). 
The red blood cells  were harvested by centrifugation of the whole blood at 
3000X G for 2 minutes. The cells were washed three times in cold Phosphate 
Buffer  Solution.   The pellet  was  resuspended in  1  ml  of  Phosphate  Buffer 
Solution.  About 10 µl of 5% saponin was added and gently mixed for a final 
concentration of 0.05%.  After  lysis  was observed,  centrifugation was done 
immediately at 6000X G for 5 min.  To the pellet, 25  µl of lysis buffer and 
75µl of distilled water was added and was incubated at 370C for approximately 
3hours with intermittent mixing by hand.  After the incubation, about 100 µl of 
distilled water and 200 µl of tris saturated phenol was added, mixed well and 
centrifuged at 12,000 rpm for 8 minutes.  The supernatant was collected and 
extracted likewise with 200  µl of chloroform.  The genomic DNA from the 
aqueous layer was then precipitated by adding 1/10 volume of sodium acetate 
and    2.5   volumes   of absolute ethanol for a couple of hours or overnight  at 
-200C.  The precipitate was centrifuged for 30 min at 40C, washed gently once 
with 70% ethanol, dried and the pellet was gently resuspended in Tris-EDTA 
(TE) buffer and stored at –200C for further use.
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Polymerase chain reaction
Primers specific for P. falciparum and P.vivax are presented in Table 1.
Table 1. Primers synthesized for detection of P. falciparum and P.vivax
PRIMER PRIMER SEQUENCE Product size
Pf 1 5’ AGA AAT AGA GTA AAA AAC AAT TTA 3’ 918 bp
Pf 2 5’ GTA ACT ATT CTA GGG GAA CTA 3’
P.v.1 5’ CCG AAT TCA GTC CCA CGT 3’ 523 bp
P.v.2 5’ GCT TCG GCT TGG AAG TCC 3’
Polymerase chain reaction was performed as per the method of Mullis 
and Falona (1987) and Saiki and co-workers (1988) using Qiagen Taq PCR 
core kit.  The kit reagents of 10X PCR buffer, dNTP mix, Q buffer and primer 
solutions were thawed and master mixture was prepared as described in Table 
2.  To the appropriate volume of master mix, template DNA was added.  The 
PCR programme was run in Biorad Gene cycler. The amplification involved 
initial  denaturation  at  94oC  for  5  minutes  and  30  cycles  of  1  minute 
denaturation  at  94 oC,  1  minute  of  annealing  at  55 oC,  1  minute  of  primer 
extension at 72 oC and a final extension at 72 oC for 10 minutes. To standardize 
the annealing temperature of the primers, a temperature gradient was run with 
the  range  from  500C  to  580C.   In  all,  8  reactions  were  run  at  annealing 
temperatures of 500C, 50.60C, 51.60C, 52.90C, 550C, 56.50C, 57.40C and 580C.
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Table 2. Standard PCR protocol
COMPONENT VOLUME (L) CONCENTRATION
10X PCR buffer 2.5 1X
Q buffer 5.0 -
dNTP mix (10mM each) 0.5 200mM of each dNTP
Primer - Pfcsp1f 0.5 0.1 – 0.5 ΜM
Primer - Pfcsp1r 0.5 0.1 – 0.5 ΜM
Taq DNA polymerase 0.25 1.25 units
Distilled water 10.75 -
Template DNA 5.0 50 ng/reaction
Total Volume 25 -
Table 3. PCR conditions
TIME TEMPERATURE
Initial denaturation 5 min 940C
3 step cycling
Denaturation 1 min 940C
Annealing 1 min 550C
Extension 1 min 720C
Repeat cycle 30 times
Final extension 10 min 720C
Agarose gel electrophoresis
The purity of the DNA was checked in submarine gel electrophoresis. 
Agarose  gel  (Sigma  Chemicals,  USA)  0.8  percent  was  prepared  in  TBE 
electrophoresis buffer (pH 7.5) containing 0.5 µg/ml concentration of ethidium 
bromide dye. The DNA samples were loaded in each of the wells of the gel 
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after solidification and run in the electrophoresis tank with TBE buffer in 100V 
along with molecular  size  marker.   The gel  was  then visualized under  UV 
irradiation.
STATISTICAL ANALYSIS
Qualitative data were given in frequencies with their  
percentages.  QBC,  ICT  and  PCR  occurrence  were  compared  with  Gold  
Standard (Peripheral blood smear) and diagnostic  statistics  like Sensitivity,  
Specificity NPV and PPV were given with their estimate and 95% Confidence  
interval.
                                 ROC curve were given for the diagnostic test results to  
represent Sensitivity and Specificity
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RESULTS
A total of 190 patients clinically diagnosed as malaria were taken up for 
this study and 40 cases of control (disease control diagnosed as enteric fever 
n=20 and healthy control n=20) were included in the study from May 2004 to 
April  2005.  Blood  samples  were  collected  from  patients  who  attended  the
in-patient  and  outpatient  departments  of  Medicine  and  Jawaharlal  Nehru 
Institute of Social Paediatrics, Government Stanley Hospital. 
190 cases were tested with peripheral blood smear and QBC. Out of this 
61 samples were selected by simple random method and tested with recent 
techniques such as ICT, Dot ELISA for P. falciparum and PCR. Control groups 
(Disease  control  n=20  and  Healthy  control  n=20)  were  also  tested  with 
Peripheral blood smear, QBC and ICT Dot ELISA for P. falciparum and PCR 
assay.  All  these  new  technologies  were  evaluated  by  comparing  with  the 
acceptated “gold standard” method. The results were analyzed statistically. 
Table-1
Results of JSB Stained Peripheral blood smear Examination n=230
S. No. Study Group
JSB Stained Peripheral 
blood smear Positive
Thick 
smear
Thin smear
P.v P.f
Positive 
Percentage
%
1. 190 cases 56 55 1 29.4
2. 20 Disease Control - - - 0
62
3. 20 Healthy Control - - - 0
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In the present study out of the 190 cases 55 were positive for P. vivax 
and 1 case positive for P. falciparum by the thin smear examination. In thick 
smear  56  cases  (29.4%)  were  positive  for  malarial  parasite  and  its  95% 
confidence interval was 23% to 36%. Disease control & Healthy control (n=40) 
were negative for malarial parasite by JSB staining method.
Table-2 (a) 
Results of QBC Assay n=230
S. No. Study Group QBC Positive
Positive 
Percentage
%
1. 190 cases 109 57.3
2. 20 Disease control 0 0
3. 20 Healthy control 0 0
Among the total of 190 clinically diagnosed cases, QBC assay detected 
the presence of malarial parasite in 109 (57.3%) cases and its 95% confidence 
interval was 50% to 64%. Control groups were found to be QBC negative. 
Table-2 (b)
Comparison between JSB stained Peripheral blood smear and QBC n=230
QBC assay
JSB Stained Peripheral 
blood smear
Positive Negative
Total
Positive 56 53 109
Negative 0 121 121
Total 56 174 230
Table 2(b) shows the sensitivity of 100% specificity of 69.5%, PPV of 
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51.3% and NPV of 100% of QBC assay. By comparing the QBC assay and 
smear method, QBC assay shows higher positivity.
Table-3 (a)
Results of Immunochromatographic test n=101
S. No. Study group ICT
Positive 
Percentage
%
1. 61 cases 32(P.v 29, Pf 3) 52.4
2. 20 Disease control 0 0
3. 20 Healthy control 0 0
32 of the 61 cases were positive for malarial parasite (P.v. 29, P.f. 3) and 
percentage positivity 52.4% by ICT method and its 95% confidence interval 
was 40% to 65%. Control groups were found to be negative by this technique.
Table-3 (b) 
Comparison between JSB stained Peripheral blood smear and Immuno 
chromatographic test (ICT) n=101
ICT
JSB Stained Peripheral 
blood smear
Positive Negative
Total
Positive 20 12 32
Negative 1 68 69
Total 21 80 101
Table 3(b) shows the sensitivity of 95.2%, specificity of 85%, PPV of 
62.5%and NPV of 98.5% by ICT method. In this present study, the sensitivity 
and specificity of ICT was higher when compared to JSB stained blood film. 
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Speciation of malarial parasites also obtained by ICT.
Table-4 (a)
Results of Dot ELISA for P. falciparum n=101
S. No. Study group
DRDE DOT 
ELISA FOR
P. falciparum
1. 61 cases 3
2. 20 Disease control 0
3. 20 Healthy control 0
Among the total 61 cases only 3 cases were positive by Dot ELISA for 
P. falciparum (DRDE). Control groups were negative by this technique. Dot 
ELISA for  P.  vivax was not done.  So this  method was not included in the 
comparative study with peripheral blood smear. 
Table-5 (a)
Results obtained by PCR n=101
S. No. Study group PCR
Positive 
Percentage
%
1. 61 cases 31(P.v 28, Pf 3) 50.8
2. 20 Disease control 0 0
3. 20 Healthy control 0 0
31 out of 61 cases were positive for malarial parasite (P.v.28, P.f.3) by 
PCR technique with a percentage positivity of 50.8% and its 95% confidence 
interval was 38% to 63%. Control groups were negative by PCR method. 
Table-5 (b)
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Comparison between PCR technique and JSB stained Peripheral blood 
smear n=101
PCR
JSB Stained Peripheral 
blood smear
Positive Negative
Total
Positive 19 12 31
Negative 2 68 70
Total 21 80 101
The sensitivity, specificity, PPV and NPV of PCR assay were calculated 
against the gold standard of Peripheral blood smear. The sensitivity of 90.5%, 
Specificity of 85%, PPV of 61.3% and NPV of 97.1% by PCR assay when 
compared to Peripheral blood smear. 
Table-6
Evaluation of recent techniques in diagnosis of malaria
Test Sensitivity Specificity PPV NPV
QBC 100% 69.5% 51.3% 100%
ICT 95.2% 85% 62.5% 98.5%
PCR 90.5% 85% 61.3% 97.1%
Out of 190 cases tested with different techniques in detecting malarial 
parasite, the predominant species identified was P. vivax.
Table-7
Positivity of malarial parasite by various techniques
67
Test No. Of sample Positive %
P. 
Vivax P. falciparum
PERIPHERAL 
BLOOD SMEAR 190 29.4 55 1
QBC 190 57.3 - -
ICT 61 52.4 29 3
PCR 61 50.8 28 3
Dot Elisa for P. 
falciparum 61 - - 3
Out  of  61 randomly selected blood samples,  32 cases  (P.v.29,  P.f.3) 
were  positive  by  ICT  method  with  positive  percentage  of  52.4%.
31 (P.v28, P.f.3) cases were positive by PCR assay, with positive percentage of 
50.8%.  Dot  ELISA  for  P.  falciparum  (DRDE)  detected  only  3  cases  of  
P. falciparum, which were also detected by ICT and PCR. In the present study 
the predominant species causing malarial infection was found to be P. vivax.
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DISCUSSION
The resurgence of malaria has renewed interest in developing not only 
preventive  measures,  but  also  rapid  diagnostic  techniques.  Several  methods 
have been developed to supplement and replace the conventional microscopic 
method. The most promising new malaria diagnostics are the Q.B.C. assay, 
Assay for detection of antigen HRP-2 and PMA by I.C.T., only HRP-2 by Dot 
ELISA  for  P.  falciparum  (DRDE)  and  detection  of  specific  nucleic  acid 
sequences (P.f. 918 bp, P.v 523bp) by P.C.R.
In the present study 190 patients clinically diagnosed as malaria were 
tested by peripheral blood smear and QBC assay for diagnosis of P. vivax and 
P.  falciparum  infection.  The  sensitivity  and  specificity  of  QBC  assay  was 
evaluated. Out of 190 samples 61 were selected by simple random method and 
tested with recent techniques such as ICT, Dot ELISA for P.falciparum and 
P.C.R. Control groups n=40 (disease control n=20, healthy control n=20) were 
also  tested  with  Peripheral  blood  smear,  QBC,  ICT,  Dot  ELISA  for  P. 
falciparum and PCR assay. 
The  results  obtained  are  discussed  as  follows.  Romanowsky  stains 
(Giemsas’,  Leishmans’,  Fields’  and  JSB)  still  appear  superior  for  species 
identification.
In the present study malarial parasite was detected in 56 (P.v. 55, P.f. 1) 
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by peripheral blood smear (29.4%).
The study by Carol J. Palmer et al in Nov 2003 (9) reported 43 (20%) 
were positive for malarial parasites by microscopy out of 216 specimen from 
patients suspected of having malaria. Iqbal J. et al in 2001 (34), had observed 
163 (31%) blood samples positive for malarial parasites by microscopy out of 
515 patients.
The above two studies are almost in correlation with the present study.
Barman.D.et al (7) reported 28 (37%) were positive for malarial parasite 
by Giemsa stained peripheral blood smear out of 74 clinically suspected cases. 
Russ Forney.J et al had observed (65) 2051 (42.1%) were positive for malaria 
by Giemsa stained peripheral blood smear out of 4873 peripheral blood smears.
One of the studies done by Krishna B.V.S. et al in 2003 (46) showed 44 
(3.07%) samples were positive by Leishman stained blood film examination 
out of 1435 blood films.
Carol J. Palmer et al in Jan 1998 (8) had reported 96 (P.v. 79, P.f. 17) 
were  positive  by  Giemsa  stained  peripheral  blood smear  (48%)  out  of  202 
patients suspected of having malaria. 
A study by Chayani N. et al (12) had observed 122 (P.v. 96, P.f. 26) 
were positive by Giemsa stained peripheral blood smear (52.5%) out of 232 
clinically suspected patients.
Pinto  MJW. et  al  2001,  (59)  reported 239 (10.5%) were  positive  by 
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Leishman stained peripheral blood smear out of 2274 patients presenting with 
pyrexia and atypical presentation.
In the present study two blood samples in which ICT, Dot ELISA for P. 
falciparum and PCR assay detected P. falciparum were found to be negative in 
blood  smear  examination.  This  may  be  explained  by  the  fact  that
P. falciparum can sometimes sequester and may not be present in circulating 
blood.
Stained peripheral blood smear examination is simple and inexpensive. 
Parasite  stages  and  species  could  be  identified  accurately.  The  main 
disadvantages are time consuming and skilled microscopist. Also it may give 
poor results with low parasitaemia 52,  57. Still the staining procedures are used 
for screening purpose.
QBC method is  based on fluorescent  staining of  the  blood cells  and 
parasites.
In  the  present  study  QBC  assay  detected  malarial  parasite  in  109 
(57.3%) cases out of 190 clinically suspected cases. This present study showed 
100% sensitivity, 69.5% specificity, PPV 51.3% and NPV 100%.
Barman.D.et  al  in  2003  (7)  reported  a  sensitivity  of  100%  and 
specificity of 100% out of 74 clinically suspected cases. Rickman et al in 1989 
(64) reported a sensitivity of 70% and specificity of 98.4% of QBC assay in 
field  condition.  However  in  hospital  condition  it  was  observed  that  the 
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sensitivity  of  this  assay  was  equivalent  to  Giemsa.  Nandwani.S  et  al  in 
2003(52) has observed 100% sensitivity and 97.5% specificity for diagnosis of 
malaria by QBC assay, out of 80 cases selected from the malaria centre.
The later two studies are almost correlations with the present study.
PINTO  M.J.W.  et  al  in  2001  (59)  had  reported  328  (14.5%)  were 
positive out of 2274 samples. Also demonstrated higher sensitivity and great 
rapidity of QBC assay as compared to Leishman stained thick and thin film.
The study done by Krishna BVS, Asha R Deshpande et al in 2003 (46) 
had observed 57 (3.97%) were positive for malarial parasite by QBC assay of 
the 1435 blood samples from patients with symptoms of the fever and chills. 
And  also  reported  a  higher  sensitivity  of  QBC  assay  as  well  as  its  rapid 
interpretation, as compared to Leishman’s stained blood film examination. 
This is a definite advantage to laboratories, which have to screen a large 
number of blood samples. Sensitivity of QBC assay varies from 97% to 100%. 
The  QBC  assay  would  be  ideal  to  supplement  stained  blood  film  in  both 
clinical and epidemiological studies. The limiting factors for QBC assay are 
cost  of  microscope,  special  accessories,  need  for  adequate  training  and 
expertise (52). The QBC tubes do not remain readable for more than a few days 
and hence cannot kept for record purposes (46).
The important factor of false positive impression of malarial parasite in 
QBC system should be considered here. In our study 8 cases of QBC positive 
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were   negative by    Peripheral blood smear, ICT   and   PCR. This could be 
Howell-Jolly bodies or artifacts such as cell debris and bacterial contamination 
(7,46).
One  of  the  serological  method,  Immuno  chromatography  Test  (ICT 
Pf/Pv) is based on the use of HRP - 2 antigen to detect P. falciparum infection 
and a pan malarial antigen (PMA) to detect P. vivax infection. In the present 
study we evaluated the performance Now ICT Malaria P.f / P.v, P.m & P.o. and 
Dot ELISA for P. falciparum (DRDE) is based on the use of HRP-2 antigen to 
detect P. falciparum only.
In the present study 32 (P.v. 29, P.f. 3) cases were positive by NOW 
ICT  method  (52.4%)  out  of  61  cases;  showed  sensitivity  of  95.2%  and 
specificity of 85% with positive and negative predictive values of 62.5% and 
98.5% respectively. 
Chayani.  N.  et  al 2004 (12) reported 118 (P.v.93, P.f.25) cases were 
positive for malarial parasite (50.8%), by OptiMAL test.
Iqbal. J. et al in 2001 (32) had observed the pLDH assay detected 133 
(P.v. 77 & P.f. 56) the cases were positive. The positive percentage was 25.7%. 
The sensitivity was 89% and specificity was 99.5%. Emiliana Tjitra et al in 
Aug 1999 (19) has observed sensitivity of 95.5% and specificity of 89.8% with 
PPV and  NPV of  88.1% and  96.2% respectively,  out  of  560  symptomatic 
adults and children with a presumptive clinical diagnosis of malaria.
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The study done by Carol J. Palmer et al in Jan 1998 (8) reported 91
(74  P.v.,  &  17  P.f.)  were  positive  by  OptiMAL  test  out  of  202  patients 
suspected having malaria. The positive percentage was 45%. This assay had 
sensitivity  of  94%  and  specificity  of  100%.  All  the  four  above-mentioned 
studies are almost in correlation with the present study. 
 Carol. J. Palmer et al in Nov 2003 (9) had observed 42 (19%) were 
positive by OptiMAL assay in a total of 216 patients suspected having malaria. 
The  sensitivity  of  the  OptiMAL  test  98%,  its  specificity  was  100%,  with 
positive & negative predictive values of 100% & 99 % respectively.
The study by Russ Forney J. et al in June 2003 (65) reported sensitivity 
of  87% and  specificity  of  87%  for  P.  vivax  and  sensitivity  of  100%  and 
specificity  of  93%  for  P.  falciparum  by  the  Parasight  F+V  assay.  The 
sensitivity of the device was 100% for P. falciparum densities of more than 500 
parasites /  µl, with a sensitivity of 83% for parasite densities of < 500/µl. For
P.  vivax  sensitivity  was  99%  with  parasite  densities  of  >5000/µl  92% for 
parasite densities 1001 to 5000/µl, 94% for parasite densities of 501 to 1000/µl 
and 55% for parasite densities of 1 to 500 / µl.
The study done by Indrani KAR et al in 1998 (32) had reported 100% 
efficiency in detection of only P.  falciparum by Parasight F test,  out  of  93 
febrile patients. In a study done by Jamshaid Iqbal et al in Sep 2004 (35) has 
observed the overall sensitivity and specificity of malarial infection. However 
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the sensitivity of this assay decreases to <70% in parasitaemia <50/µl, out of 
240 patients with P. falciparum mono infection.
 
Various  studies  mentioned  above  are  almost  in  correlation  with  the 
present study. 
In the present study Dot ELISA detected only 3 cases of P. falciparum 
for P. falciparum (DRDE), which were also detected by ICT and PCR assay, 
thereby indicating 100% efficiency in detection of P. falciparum cases.
We should consider the merits  and demerits  of ICT compared to the 
“gold standard”.  ICT assay is  rapid and not labor intensive64.  It  could be a 
useful adjunct to blood film microscopy and might permit a reduction in the 
duration  of  hospitalization  and  give  an  early  warning  of  treatment  failure1. 
Furthermore  advantage of  ICT assay  is  speciation and can also  be  used to 
indicate drug resistant infection60. 
The  demerits  of  ICT assay  are  false  positivity  due  to  persistence  of
HRP 2 and pLDH antigenemia after antimalarial therapy35. Factors that may 
contribute to these diverse findings include test kit storage conditions in the 
field inadequate adherence to the test protocol, or levels of parasitaemia below 
the detection limit 9.
In our study one case of P. vivax detected by Peripheral blood smear & 
QBC  were  not  detected  by  ICT.  This  may  be  due  to  insufficient  enzyme 
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production, which occurs during early malarial infection or the patient’s blood 
sample-contained parasites at concentration below the detection level12. 
There  are  many  published  studies  showing  the  improved  sensitivity
and  specificity  of  PCR-based  assay  over  microscopic  and
immunochromatographic diagnosis of malaria 43.
In the present study PCR assay detected malarial parasite in 31 (28P.v. 
3Pf) with positive percentage of 50.8% out of 61 clinically suspected cases. 
This present study showed, sensitivity of 90.5% and specificity of 85%, PPV of 
61.3% and NPV of 97.5%.
On performing PCR test by Barman. D. et al in 2003 (7) showed that 
PCR-Pf had a sensitivity of 64.28%, specificity of 100%, PPV of 100% NPV 
of 88.37%, out of 104 blood samples. Long et al (48) found the sensitivity of 
94.6% at the parasitaemia level of 616/µl of blood.
Above mentioned studies are in correlation with the present study.
Kathy  et  al  in  May  2005  (43)  reported  76  cases  were  positive  by 
microscopy  out  of  358  clinically  suspected  patients,  real-time  PCR  assay 
detected malarial parasite in 74 (97.4%) cases out of 76 smear positive case. 
Perandin. F. et al in Mar 2004 (57) reported that PCR assay detected malarial 
parasites in all 60 smear positive samples (100% sensitivity), with no detection 
of  plasmodium  in  the  remaining  60  smear  negative  blood  samples  (100% 
specificity) out of 122 clinically suspected patients.
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The  study  done  by  Mathieu  Rougemont  et  al,  in  Dec  2004  (50) 
compared  with  results  of  microscopy  and  real-time  PCR  and  had  a  crude 
agreement of 86% for the detection of Plasmodium infection, out of 97 blood 
samples. Jamshaid Iqbal et al in Nov 1999 (36) had observed 145 (P.v. 120, P.f. 
43 & 2 mixed infection) with positive percentage of 26% out of 550 clinically 
suspected patients. Jill M. Tham et al in May 1999 (41) showed that the results 
obtained by PCR were equivalent or superior to those obtained by microscopy, 
out of 52 patients were identified as being infected with malaria by blood film 
analysis and QBC analysis.
In our study 2 cases of both JSB stained Peripheral blood smear and 
QBC assay positive,  were revealed negative by PCR assay (False negative). 
False negative result in PCR could be due to the failure of amplification of 
target DNA. The failure to amplify the target amplicons could be due to low 
copy number of the target sequence to the primer. Absence of target sequence 
could be due to degradation of the parasitic nucleic acids during the sample 
preparation  and  storage.  Inaccessibility  to  target  sequence  could  be  due  to 
inadequate cellular lysis. The presence of PCR inhibitors in the DNA solution 
could reduce the yield of the amplified products to below the detection level of 
ethedium bromide staining. Further more, excess of human DNA present in the 
sample can also inhibit the PCR reaction and can lower the sensitivity.
False positive results in PCR could also be due to carry over of parasite 
– DNA during sample processing or lower sensitivity of the designed primer 
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and PCR method itself. (7)
PCR  has  enabled  wide-ranging  investigations  of  antimalarial  drug 
resistance polymorphisms and polymorphic antigen based strain diversity in the 
context  of  malarial  vaccine  trails.  The  limit  of  PCR-based  detection  of 
Plasmodium from whole blood is approximately 1 to 5 parasitized erythrocytes/
5x106 erythrocytes / µl (0.0001% parasitaemia)17.
Real  time  PCR  with  melting  curve  analysis  could  be  a  rapid  and 
objective supplement to the examination of Giemsa stained blood smears and 
may replace microscopy following further validation (43).    
Despite the advantages of PCR, it  is  unlikely to be useful outside of 
well-equipped laboratories where a reliable source of electricity and expensive 
equipment are not available. These limitations exclude PCR from consideration 
as a field – ready rapid diagnostic test for malaria17.
Unfortunately, conventional PCR assay are technically demanding and 
time-consuming. More over, they are prone to carryover contamination during 
the manipulation of post amplification products50.
Laboratory methods that require more than 1 hour to provide a clear 
diagnosis  of  malaria  are  not  considered  rapid  tests.  Therefore,  PCR cannot 
strictly be considered a rapid technique for the initial diagnosis of malaria at 
present.  Currently  such  procedures  have  been  established  as  a  second  line 
diagnosis for patients with high clinical suspicion of malaria but a negative 
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microscopy or when difficulty in species identification occurs 50.
In  the  present study the  predominant  species  identified was P.  vivax 
Government Stanley Hospital is located in North Chennai. In North Chennai 
12,239 cases were diagnosed as malaria by microscopy during 2004. Out of 
this 11,861 cases were vivax malaria and 378 cases were falciparum malaria. 
During  2005  malaria  positive  cases  were  10,666.  Out  of  this  10417  were
P. vivax and 249 were P. falciparum (Courtesy of Chennai Corporation).
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SUMMARY
In the present study 190 blood samples from patients with symptoms of 
fever  and  chills  (clinically  diagnosed  as  malaria),  20  blood  samples  from 
enteric  fever  cases  (disease  control)  and  20  blood  samples  from  healthy 
individuals  were  collected  and  subjected  to  various  techniques  in  detecting 
malarial parasites.
All the 190 cases were tested by JSB stained Peripheral blood smear and 
Q.B.C. assay. Malarial parasite was detected in 56 (P.v. 55, P.f 1) cases by JSB 
stained Peripheral blood smear (29.4%). 109 cases were found to be positive by 
Q.B.C.  assay  (57.3%).  Control  groups  (Disease  control  & Healthy  control) 
were also tested by Peripheral blood smear,  QBC, ICT, DOT ELISA for P. 
falciparum and PCR assay.  None of control samples were positive for malarial 
parasite.
Among  the  190  cases,  61  blood  samples  were  selected  by  simple 
random method and tested by recent diagnostic tests such as ICT, Dot ELISA 
for P. falciparum and PCR and compared with the “gold standard” JSB stained 
Peripheral blood smear.
Out of 61 randomly selected blood samples 32 cases (P.v. 29, P.f. 3) 
were  positive  by  ICT  method  with  positive  percentage  of  52.4%.
80
31 (P.v 28, P.f. 3) cases were positive by PCR assay with positive percentage 
of  50.8%. Dot ELISA for P.  falciparum (DRDE) detected only 3 cases of  
P. falciparum, which were also detected by ICT and PCR. In the present study 
the predominant species causing malarial infection was found to be P. vivax.
In our study Peripheral blood smear is the simple and inexpensive test 
for detection of malarial parasite, and the QBC assay was found to be more 
sensitive.  The  recent  techniques  of  I.C.T.,  DOT  ELISA  for  P.  falciparum 
(DRDE) and PCR assay are found to be more sensitive, specific and accurate 
enough to identify the Plasmodium species.
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CONCLUSION
1. 190  clinically  diagnosed  cases  of  malaria  were  tested  by  JSB  stained 
Peripheral blood smear and QBC assay.
2. 29.4% were positive by JSB stained Peripheral blood smear
3. 57.3% were QBC positive
4. Out of this 61 blood samples were selected by simple random method and 
tested by ICT, DOT ELISA for P. falciparum (DRDE) and PCR assay.
5. 52.4% were positive by antigen detection assay (HRP-2, PMA) by ICT P.f/
P.v method.
6. 50.8% were PCR positive.
7. 3 cases were positive by DOT ELISA for P. falciparum (DRDE).
8. P. vivax was the predominant species causing malarial infection.
Malaria rapid diagnostic devices (MRDD) have been developed with the 
hope that they would offer accurate, reliable, rapid, cost effective and easily 
available  alternatives  to  traditional  methods  of  malaria  diagnosis.  In  future 
MRDDs will play an increasing role, where reliable microscopy is frequently 
poor. The new generation of non-microscopic immunochromatographic assay 
offers  a  practical  chance  to  move  the  diagnosis  of  malaria  away  from the 
laboratory and nearer to the patient.
New rapid non-microscopy methods for the diagnosis  of malaria that 
complement or support microscopy of blood films would be of great use in the 
early diagnosis and treatment of patients with malaria and in epidemiological 
studies. 
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PROFORMA
Case study No. :
I.P. No. / O.P. No. :
Name :
Age / Sex :
Address :
Socioeconomic group :
Occupation :
Present H/o :
- Fever : Duration
 Periodicity
- Rigor
- Head ache
- Seizure
- Vomitus
- Treatment taken
On examination :
- Temperature 
- Pulse
- B.P.
- Pallor
- Icterus
- Sensorium
Orientation to time, Place and to person, 
- Liver size
- Spleen size
Past H/o. : Previous attack of malaria and treatment.
Investigation :
- Peripheral smear (thick and thin)
- Q.B.C.
- ICT
- ELISA
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- PCR
APPENDIX
I. Jaswant singh – Bhattacharjee stain (JSB stain)  
JSB I : Methylene blue -
0.5 gm
1% sulphuric acid -
3CC
Potassium dichromate -
0.5 gm
Disodium hydrogen
phosphate dihydrate -
3.5 gm
Distilled water -
500 CC
JSB II : Eosin yellow -
1 gm
Distilled water -
500 CC
Buffer water : Water -
1000 CC
Disodium hydrogen phosphate -
0.22 g
Potassium acid phosphate -
0.74 gm
Procedure :
Thin smear preparation – After air drying, fix in methanol dip in stain 
JSB II (2-3 sec) ; wash with buffer water to remove excess stain. Dip in stain 
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JSB I (40-60 sec) ; Dry the smear and observe under oil immersion.
Thick  smear  :  Dehaemoglobinization  using  buffer  water  for  5-10 
minutes. Continue as for thin smear. 
Kit Contents for ICT :
Individually packaged test cards.
Capillary tubes.
Malaria Reagent A.
Product insert.
Procedure card.
Kit contents of Dot ELISA for P. falciparum (DRDE) :
- Two-tip nitrocellulose vials
- Dilution buffer
- Conjugate
- Substrate powder
- Substrate buffer
- Wash buffer
- Monoclonal antibody
- Metal Spoon
- Safety pin
- Syringe
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ABBREVIATION
DRDE - Defence Research and Development Establishment
ELISA - Enzyme Linked Immuno-Sorbent Assay
HRP - Histidine Rich Protein
ICT - Immuno Chromatographic Test
JSB - Jaswant Singh Bhattacharjee
MRDD - Malaria Rapid Diagnostic Device
NPV - Negative Predictive Value
PCR - Polymerase Chain Reaction
pLDH - Parasite Lactate Dehydrogenase
PPV - Positive Predictive Value
QBC - Quantitative Buffy Coat
ROC - Receiver Operating Curve
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